Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,710 total articles
A Form 4 filing disclosed multiple transactions involving John Gordon Freund, a director at Collegium Pharmaceutical. The filings detail share sales and the exercise of stock options that occurred in May 2026. These insider movements are noted alongside recent positive company disclosures, including strong first-quarter earnings per share (EPS) and…
Sanjay Munshi, the Chief Operating Officer of Netscout Systems Inc., executed a sale of company stock on May 15, 2026. This transaction occurred while the firm released its fourth-quarter fiscal year 2026 earnings report, which revealed mixed financial results: revenue surpassed expectations but earnings per share fell short.
The latest filings reveal that NovaBridge Biosciences (NASDAQ:NBP) Chief Business Development Officer, Sean Wuxiong Cao, sold company shares valued at $42,584. This insider activity is reported against a backdrop of significant clinical progress for the firm's drug pipeline and recent positive analyst coverage.
A director at CareDx, Inc. has reported the sale of over 10,500 shares of common stock, totaling approximately $214,675. This insider activity occurred while the company announced robust first-quarter financial results for 2026 and revealed a significant strategic move to acquire Naveris. The earnings report showed EPS beating expectations, with te…
Chief Compliance Officer James O. Hearty sold approximately $2.91 million worth of common stock from DaVita Inc. (NASDAQ:DVA) on May 15, 2026. This divestment occurred shortly after Mr. Hearty exercised Stock Appreciation Rights (SARs), which resulted in the acquisition of additional shares. The transaction takes place against a backdrop of strong …
Michael Ellenbogen, a director at Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), recently executed a substantial sale of company stock. This transaction occurred alongside recent operational news, including a strong first-quarter revenue performance and an upward revision in full-year guidance. These developments, however, have been accompanied b…
Lee E. Lyon II, an executive at First Commonwealth Financial Corp (FCF), recently divested common stock worth approximately $644,054. This sale occurred amid mixed financial reports for the company in 2026, including first-quarter earnings and revenue figures that fell short of analyst expectations.
Executive Vice President, Secretary, and Chief Legal Officer Van H. Beckwith sold approximately $8.19 million worth of Halliburton common stock in multiple transactions. This sale occurs while the company's stock trades near its 52-week high and amid positive developments such as a major consulting agreement with Greenland Energy Company and increa…
Robert H. Fries, Chief Executive Officer of Encision Inc., recently executed significant purchases of the company's common stock, indicating a substantial commitment to holding the shares. These acquisitions occurred on April 15 and April 16, 2026, involving transactions totaling $24,024.The CEO acquired a combined total of 166,785 shares through t…
David M. Lobach Jr., Chairman, President, and CEO of Embassy Bancorp, Inc., recently purchased a tranche of the company's common stock. This transaction increases his direct ownership stake just as the stock trades near its 52-week high and boasts a long history of dividend increases. The purchase provides insight into internal perception regarding…
Ann M. Kappler, Executive Vice President and General Counsel at Prudential Financial Inc., recently sold a substantial portion of her company stock, totaling approximately $1.4 million. This transaction occurred as the market continues to digest various corporate developments for PRU, including a newly announced quarterly dividend, board elections,…
The recent purchase of common stock by director Anthony Folger suggests internal confidence in CSP Inc. (NASDAQ:CSPI). This activity occurs against a backdrop of the stock trading down year-to-date, while the company simultaneously reported positive Q2 FY2026 earnings, showing significant revenue growth and a return to profitability.
Kevin B. Kramer, a director at Kronos Worldwide Inc., recently acquired shares totaling $98,509 on May 18, 2026. This insider buying activity occurred while the company's stock experienced notable volatility over recent periods. The accumulation of shares boosts his personal direct ownership stake in KRONOS WORLDWIDE INC.
Christopher Bohrson, Senior Vice President and Chief Customer Officer at Cohu Inc., sold common stock valued at $46,920 on May 15, 2026. This sale was executed under a pre-arranged 10b5-1 trading plan. Despite the executive selling shares, recent company disclosures show mixed first-quarter performance, although major semiconductor orders and posit…
The article details a significant insider transaction involving Globalfoundries' Chief Legal Officer, Azar Samak L. Concurrently, it provides an update on the company's financial health, noting strong Q1 2026 performance, upcoming dividends, and positive revisions to price targets from major investment banks.
A director at Southern Copper Corp sold a specified amount of common stock shares recently. This transaction occurs against a backdrop of significant corporate developments, including the appointment of a new Chief Executive Officer and an upgrade from Goldman Sachs. The article also notes that copper prices are rising, influenced by factors such a…
AeroVironment Inc. director, Stephen F. Page, executed a sale of company shares totaling $40,577. This transaction occurred while the stock was trading near its 52-week low. Despite this insider activity, recent corporate developments for AeroVironment include securing a significant three-year contract with the Department of War and passing an FAA …
Andrew J. Briggs, a director at Farmers & Merchants Bancorp Inc., recently sold shares totaling $159,690 over two days in mid-May. Separately, the company announced a 4% increase to its quarterly cash dividend, alongside internal promotions and the re-election of multiple directors, signaling continued strategic activity.
Joseph Colella, SVP and General Counsel at Entegris Inc., recently sold a significant block of company stock valued at $886,715. This transaction occurred following his acquisition of an equivalent number of shares through the exercise of employee stock options. The report details these movements alongside recent corporate developments, including s…
Clint Haris, SVP & President of the APS Division at Entegris Inc., recently sold a significant block of common shares. This transaction occurred against a backdrop of positive operational news for the company, including better-than-expected first-quarter 2026 financial results and notable leadership transitions within its Materials Solutions divisi…
The recent stock transactions involving Entegris Inc.'s Senior Vice President, Olivier Blachier, coincide with the company's announcement of favorable first-quarter 2026 financial results and a significant internal leadership transition within its Materials Solutions division. Mr. Blachier sold shares on May 14, 2026, after exercising employee stoc…
Susan G. Rice, Senior Vice President of Global Human Resources at Entegris Inc., sold nearly 2.7 million dollars worth of shares on May 15, 2026. This activity occurred as the stock has shown significant price fluctuations recently. Separately, Entegris reported strong first-quarter 2026 financial results and announced a leadership change in its Ma…
NIQ Global Intelligence plc director James M Peck acquired a significant block of the company's ordinary shares in May 2026. This buying activity occurs while NIQ stock trades near its 52-week low, following a period where the firm reported strong first-quarter financial results but simultaneously faced reduced price targets from major analyst firm…
Aquestive Therapeutics' President and CEO, Daniel Barber, executed a sale of company stock totaling $35,413. This transaction occurs amidst positive operational developments for the firm, including surpassing first-quarter 2026 earnings expectations and confirming key regulatory timelines for its drug pipeline.
A significant insider transaction was reported involving William M. Gottwald, a ten percent shareholder in TREDEGAR CORP (NASDAQ:TG), who sold a total of $97,096 worth of common stock over two days in mid-May 2026. The report details the sale mechanics and remaining indirect holdings. Separately, the article notes recent corporate developments at T…
